Navigation Links
Mayor Greg Ballard to Join Roche Diagnostics Leaders at Groundbreaking of New Learning and Development Center
Date:11/12/2012

INDIANAPOLIS, Nov. 12, 2012 /PRNewswire/ -- Roche Diagnostics, a world leader in pharmaceuticals and diagnostics, announced in June its plans to invest $300 million during the next 10 years in expanding its North American headquarters located on the northeast side of Indianapolis.  The first phase of the project is a new Learning and Development Center, where approximately 1,500 customers from across the nation will be trained each year. 

Mayor Greg Ballard will be joined by Roche Diagnostics President and CEO Jack Phillips along with members of the City-County Council and community leaders to break ground on the expansion and unveil renderings of the new building, which will have a distinct architectural style.  WHO: Mayor Greg BallardJack Phillips, President and CEO, Roche DiagnosticsMembers of City-County CouncilWHEN:Wednesday, November 14, 201210:00 A.M. Eastern Standard TimeWHAT:Groundbreaking Ceremony for Roche Diagnostics Learning and Development CenterWHERE:Roche Diagnostics Campus – Near Entrance 49115 Hague Road, Indianapolis, IndianaRSVP:Please RSVP to Jacque Robertson at jacque.robertson@roche.com or (317) 521-2819Due to limited parking on corporate campus, RSVPs are appreciated.NOTE:Press riser with mult box to be provided.  Principals will be made available to press following event. About Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2011, Roche had over 80,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 42.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

All trademarks used or mentioned in this release are protected by law.For further information, please contact: Todd Siesky Director, Corporate Communications

Roche Diagnostics

Indianapolis, IN(317) 521-3966 O

(317) 361-7637 Ctodd.siesky@roche.com

  


'/>"/>
SOURCE Roche Diagnostics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New York City Mayor Bloomberg and Health Commissioner Farley Receive Flu Shot at Duane Reade Pharmacy, Highlight Importance of Flu Preparedness
2. Rochester Medical Corporation Announces Decision To Exit The Foley Catheter Business
3. Rochester Medical Announces Fourth Quarter 2012 Earnings Conference Call Tuesday, November 13, 2012
4. Roche cytomegalovirus viral load test now available in US
5. Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets
6. Roche receives FDA clearance for herpes simplex virus type 1 and 2 tests
7. Rochester Medical Reports Third Quarter Results
8. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
9. Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
10. FDA clears Accu-Chek Combo system - Roches new interactive insulin pump system for people with diabetes
11. Roche announces FDA approval of HIV viral load test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 Orthopedic Implants (Including Spinal Implants, ... to Gain a Significant Market Share Owing to a Large ... ... According to a new report by Persistence ... Packaging: Clamshell Product Type Segment Projected to Witness a Significantly ...
(Date:12/2/2016)... MONMOUTH JUNCTION, N.J. , Dec. 2, 2016 /PRNewswire/ ... critical care immunotherapy leader commercializing its European Union approved ... in critically-ill and cardiac surgery patients worldwide, announced that ... present at the 9th Annual LD Micro Main ... 8 th , 2016 at the Luxe Sunset Boulevard ...
(Date:12/2/2016)... NEW YORK , December 2, 2016 ... at 5,251.11, down 1.36%; the Dow Jones Industrial Average edged ... closed at 2,191.08, down 0.35%. Losses were broad based as ... Today, Stock-Callers.com has initiated research reports on the following Services ... N.V. (NASDAQ: QGEN ), INC Research Holdings Inc. ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh ... generation fits into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, ... showing how the details line up exactly with Bible Prophecy – a protected way ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health ... has raised $6.0 million in an initial round of funding. The round was ... and their caregivers can receive far better care through the application of the ...
(Date:12/2/2016)... ... December 02, 2016 , ... Today CloudMine, a secure, ... was named the best Sales Team of 2016 as part of the 2016 ... by the Software & Information Industry Association (SIIA), the principal trade association for ...
(Date:12/2/2016)... FL (PRWEB) , ... December 02, 2016 , ... ‘Tis ... are winners of $1,000 each from the National Family Partnership and the Drug Enforcement ... families who decorated their homes and the 10 winning schools who decorated their campuses ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... they now offer a comprehensive in-house dental plan for all patients. Understanding that ... a plan that gives patients a number of perks, including discounts on many ...
Breaking Medicine News(10 mins):